- Global Pharma News & Resources

Press Releases

Date Title Company
16-Feb-2019 Pivotal Phase III Data for BAVENCIO® (avelumab) Plus INLYTA® (axitinib) in Advanced Renal Cell Carcinoma Published in the New England Journal of Medicine Merck KGaA
16-Feb-2019 L-Carnitine Market Size, Status, Dynamic, Growth, Share And Foresight 2019-2028 Wired Release
16-Feb-2019 Global Hepatitis E Diagnostic Tests Market Analysis By Key Vendors, Segmentation, Region-wise Analysis Forecast To 2028 Wired Release
16-Feb-2019 Global Genotyping Market Key Players, Competitive Strategies, Regional Analysis Forecast 2028 Wired Release
16-Feb-2019 Genome Engineering Market Detailed Analysis On Forthcoming Development And Forecast By 2028 Wired Release
16-Feb-2019 Global Gene Expression Analysis Market: Industry Status, Sales Outlook, Supply-Demand Analysis 2019-2028 Wired Release
15-Feb-2019 U.S. and EU Patent Office Decisions Invalidate Amgen Subsidiary Immunex's Patents Claiming Antibodies to the IL-4 Receptor Regeneron Pharmaceuticals, Inc.
15-Feb-2019 Marker Therapeutics Announces Change in Corporate Headquarters and Access to New Laboratory Facility Marker Therapeutics, Inc.
15-Feb-2019 American Regent Re-introduces Droperidol Injection, USP; AP Rated and Therapeutically Equivalent to Inapsine®1* American Regent, Inc.
15-Feb-2019 Clinical Data Presented from PIVOT-02 Study of Bempegaldesleukin (NKTR-214) with Nivolumab in Metastatic Urothelial Carcinoma Patients at the 2019 ASCO Genitourinary Cancers Symposium Nektar Therapeutics
15-Feb-2019 Realm Therapeutics plc ("Realm Therapeutics", "Realm" or the "Company"), Update on Strategic Review, Proposed Assets Disposal, Proposed Adoption of Investing Policy, Proposed AIM Delisting and Notice of General Meeting Realm Therapeutics
15-Feb-2019 CVS Health to Present at the SVB Leerink Global Healthcare Conference CVS Health Corporation
15-Feb-2019 FDA advances new efforts to promote development of safe and effective regenerative medicine products U.S. Food and Drug Administration
15-Feb-2019 Avapritinib receives Phase III clinical trial approval for GIST in China CStone Pharmaceuticals
15-Feb-2019 Avapritinib receives Phase III clinical trial approval for GIST in China CStone Pharmaceuticals
15-Feb-2019 Statement from FDA Commissioner Scott Gottlieb, M.D., on new policy to improve access and foster price competition for drugs that face inadequate generic competition U.S. Food and Drug Administration
15-Feb-2019 Bayer to obtain full rights to global development and commercialization of oncology compounds Vitrakvi® (larotrectinib) and BAY 2731954 (LOXO-195) Bayer
15-Feb-2019 Lilly Completes Acquisition of Loxo Oncology Eli Lilly and Company
15-Feb-2019 Near Infrared Imaging Market Worth $822 Million by 2023 - Exclusive Report by MarketsandMarkets™ MarketsandMarkets
15-Feb-2019 Insmed to Host Fourth Quarter and Full Year 2018 Financial Results Conference Call on Friday, February 22, 2019 Insmed Incorporated